NewsRoom Articles - Page 207 of 620

WednesdayApr 27, 2022 4:20 pm

420 with CNW — Top Democrat in Florida Sues Federal Government Over Gun Rights of Marijuana Users

Cannabis users in America often run afoul of federal law for consuming state-legal cannabis. Since federal law still classifies cannabis as a Schedule I controlled substance with no accepted medical applications and a high risk of abuse, federal institutions strictly prohibit it. The result is cannabis users being penalized for engaging in actions that are legal in their home states. This includes a federal rule that prohibits marijuana users from purchasing a gun. Gun buyers have to fill out a federal form that includes a question on whether or not they use cannabis. The form explicitly states that cannabis is…

WednesdayApr 27, 2022 9:30 am

O’Cannabiz Conference Expo & Awards to Boost Local Cannabis Trade and Networking

Explore the world of cannabis and navigate the immense networking opportunities offered at the O’Cannabiz Conference Expo & Awards from June 1-3, 2022. This event offers a phenomenal stage for traders, cultivators, marketers, regulators, researchers, and cannabis businesses in the region to get recognition on the global forum, amongst the stalwarts of the cannabis space. This year, the conference is being organized by O’Cannabiz Conference Expo & Awards as a physical event at the International Centre- Hall#5, Ontario, Canada, after being canceled last year due to COVID-19. The Conference and Expo will be held at the 50,000 sq. ft hall…

WednesdayApr 27, 2022 9:30 am

Lift&Co. Expo Toronto 2022 – Lift Cannabis Business Conference To Offer Important Learning and Networking Sessions

Become a part of Canada’s #1 Cannabis Conference and Trade Show for a full-day immersive learning experience about Cannabis business and trade at the Lift Cannabis Business Conference on May 12, 2022. The business conference is a part of the 4-day Lift&Co. Expo Toronto 2022 that is being held at the Metro Toronto Convention Centre. The Cannabis Business Conference will be attended by cannabis business leaders from across North America and around the world and will feature speaker sessions and presentations to impart the latest intelligence on myriad aspects of the cannabis industry. Connect with the experts, innovators, regulators, and…

WednesdayApr 27, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Fourth Human Study for Reducing Hypertension, Reports Positive Outcome of Third Human Study’s Data

Global drug delivery innovator Lexaria Bioscience is researching the ability of its patented DehydraTECH(TM) technology to improve the performance of a number of prescription drugs Lexaria is a world leader in the investigation of a DehydraTECH-processed cannabidiol (“CBD”) to potentially treat high blood pressure (hypertension), and study outcomes thus far have rendered positive results on effectiveness and patient tolerance The company is building a scorecard of data to support its planned FDA application for formal, registered clinical testing under the Investigational New Drug (“IND”) process Lexaria recently completed all data analyses of its HYPER-H21-3 study examining DehydraTECH-CBD’s ability to reduce…

WednesdayApr 27, 2022 4:20 am

420 with CNW — New Poll Suggests Parents Are Willing to Give Kids CBD

Cannabidiol (CBD) is a chemical compound produced by plants in the cannabis family. Since most of the CBD on the American market is extracted from hemp, a nonpsychoactive form of cannabis, cannabidiol will not intoxicate you. For the past couple of years, people have been turning to this hemp extract as an alternative medicine for a variety of health problems. Studies have shown that it can be effective at alleviating the symptoms of medical conditions such as chronic pain, anxiety depression and insomnia. Furthermore, the FDA has approved a CBD-based drug called Epidiolex to treat two rare forms of pediatric…

TuesdayApr 26, 2022 4:20 pm

420 with CNW — A Look at the Relationship Between Different Social Media Platforms and Marijuana

The cannabis industry operates in a sort of regulatory limbo where dozens of states have legal cannabis markets, but federal law explicitly outlaws the production and sale of cannabis. This means that although marijuana businesses pay taxes, there are significant restrictions placed on them by federal legislations. One restriction placed on the cannabis industry is on advertising. For example, because the controversial plant is considered a Class I controlled substance with a high potential for abuse, the Cannabis Control Commission in Massachusetts doesn’t allow cannabis businesses to advertise on most platforms unless data shows that they can reasonably expect at…

TuesdayApr 26, 2022 4:25 am

420 with CNW — Marijuana Firms Boost Online Sales by Leveraging UX Design

Due to restrictions placed on the cannabis market by federal prohibition, players in the nascent industry cannot market or sell their products through regular chains. Furthermore, patchwork cannabis regulations make it extremely tricky for cannabis businesses to expand to other states. As a result, many cannabis businesses across the country are tapping into a resource that has essentially revolutionalized commerce: the internet. By building navigable and user-friendly websites, cannabis businesses can open up their market base without having to spend millions of dollars opening stores out of state. Marijuana businesses are now investing in user-experience (UX) design to ensure their…

MondayApr 25, 2022 4:20 pm

420 with CNW — Analysis Shows Access to Recreational Cannabis Reduces Prescription Drugs Demand

Prescription drugs have got to be among the most influential human inventions of all time. Thanks to these medications, people have been able to recuperate from illnesses and injuries that would have otherwise taken their lives. However, prescription medications aren’t without risk. Some of these medications have such serious side effects that they actually reduce the quality of life of patients while they are going through treatment. As such, there has been a push for alternative medicines for the past couple of years. Cannabis has emerged as a possible alternative to pharmaceuticals. In fact, a recent analysis by researchers from…

MondayApr 25, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Advancing DehydraTECH-Nicotine Research to Support Safer, More Effective Oral Alternative to Harmful Pulmonary Administration Practices

Lexaria expects to begin dosing this summer as part of a human nicotine study, NIC-H22-1, to compare DehydraTECH-nicotine pouch performance to that of existing leading brands such as ON! and Zyn So far, the company’s animal studies have evidenced that the technology delivers outstanding results, including faster delivery, an increase in the quantity of peak nicotine delivered, higher brain levels of nicotine, and enhanced bioavailability In its most recent study, Lexaria established that DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls and peak levels achieved were up to 10x higher than controls Lexaria’s research aims to…

MondayApr 25, 2022 4:20 am

420 with CNW — Schumer Postpones Tabling Cannabis Legalization Bill as Consultations Continue

Senate Majority Leader Chuck Schumer has made it clear that he is a strong supporter of comprehensive marijuana reform at the federal level. For the past couple of months, he has been working with Senator Cory Booker and Senate Finance Committee Chair Ron Wyden on a bill that would federally legalize cannabis and regulate sales. Dubbed the Cannabis Administration & Opportunity Act (CAOA), Schumer’s bill was first unveiled in 2021 to mixed reviews. The draft bill intended to deschedule cannabis at the federal level, expunge prior nonviolent cannabis convictions from people’s records, allow states to continue running their own cannabis…

News and publishing service for cannabis related companies

Contact us: 512.354.7000